QuadMedicine, Inc. (KOSDAQ:464490)

QuadMedicine Statistics

Total Valuation

QuadMedicine has a market cap or net worth of KRW 153.06 billion. The enterprise value is 133.02 billion.

Market Cap	153.06B
Enterprise Value	133.02B

Important Dates

The next estimated earnings date is Thursday, May 7, 2026.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

QuadMedicine has 11.48 million shares outstanding. The number of shares has increased by 10.14% in one year.

Current Share Class	11.48M
Shares Outstanding	11.48M
Shares Change (YoY)	+10.14%
Shares Change (QoQ)	+5.31%
Owned by Insiders (%)	25.54%
Owned by Institutions (%)	4.32%
Float	7.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.31
PB Ratio	4.97
P/TBV Ratio	5.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-19.19
EV / Sales	12.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.74

Financial Position

The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.24.

Current Ratio	2.87
Quick Ratio	2.75
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	-1.11
Interest Coverage	-18.24

Financial Efficiency

Return on equity (ROE) is -32.69% and return on invested capital (ROIC) is -13.94%.

Return on Equity (ROE)	-32.69%
Return on Assets (ROA)	-9.58%
Return on Invested Capital (ROIC)	-13.94%
Return on Capital Employed (ROCE)	-15.82%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.26
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	15,855.20
200-Day Moving Average	n/a
Relative Strength Index (RSI)	40.44
Average Volume (20 Days)	163,669

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, QuadMedicine had revenue of KRW 10.70 billion and -6.93 billion in losses. Loss per share was -722.00.

Revenue	10.70B
Gross Profit	10.70B
Operating Income	-6.38B
Pretax Income	-6.93B
Net Income	-6.93B
EBITDA	-3.09B
EBIT	-6.38B
Loss Per Share	-722.00

Balance Sheet

The company has 27.52 billion in cash and 7.48 billion in debt, with a net cash position of 20.03 billion or 1,744.72 per share.

Cash & Cash Equivalents	27.52B
Total Debt	7.48B
Net Cash	20.03B
Net Cash Per Share	1,744.72
Equity (Book Value)	30.80B
Book Value Per Share	3,049.49
Working Capital	20.22B

Cash Flow

In the last 12 months, operating cash flow was -4.55 billion and capital expenditures -2.19 billion, giving a free cash flow of -6.74 billion.

Operating Cash Flow	-4.55B
Capital Expenditures	-2.19B
Depreciation & Amortization	3.30B
Net Borrowing	-357.49M
Free Cash Flow	-6.74B
FCF Per Share	-586.83

Margins

Gross margin is 100.00%, with operating and profit margins of -59.67% and -64.79%.

Gross Margin	100.00%
Operating Margin	-59.67%
Pretax Margin	-64.79%
Profit Margin	-64.79%
EBITDA Margin	-28.86%
EBIT Margin	-59.67%
FCF Margin	n/a

Dividends & Yields

QuadMedicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.14%
Shareholder Yield	-10.14%
Earnings Yield	-4.53%
FCF Yield	-4.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

QuadMedicine has an Altman Z-Score of 5.15 and a Piotroski F-Score of 3.

Altman Z-Score	5.15
Piotroski F-Score	3